Acerus Reports Fourth Quarter and Full Year 2016 Financial Results

07:00 EST 8 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Total revenues of $24.5 million for the year Significant improvement in EBITDA for the year Earnings per share of $0.05 for 2016 Strengthened balance sheet vs. 2015 ...

Other Sources for this Article

Acerus Pharmaceuticals Corporation
Tricia Symmes, 289-327-1499
Chief Operating Officer


More From BioPortfolio on "Acerus Reports Fourth Quarter and Full Year 2016 Financial Results"

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...